Direxion Daily S&P Biotech Bull 3X ETF
LABU
39 hedge funds and large institutions have $56.9M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 7 closing their positions.
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
52% more capital invested
Capital invested by funds: $37.4M → $56.9M (+$19.5M)
47% more call options, than puts
Call options by funds: $109M | Put options by funds: $74.3M
18% more funds holding
Funds holding: 33 → 39 (+6)
0.9% more ownership
Funds ownership: 6.4% → 7.3% (+0.9%)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$6.49M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.57M |
| 3 |
IMC Chicago
Chicago,
Illinois
|
+$2.87M |
| 4 |
Morgan Stanley
New York
|
+$2.55M |
| 5 |
Goldman Sachs
New York
|
+$2.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
-$15.6M |
| 2 |
Squarepoint
New York
|
-$6.2M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.21M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$444K |
| 5 |
RC
RBF Capital
San Francisco,
California
|
-$378K |
LABU Hedge Fund Activity: Q3 2025 in Review
39 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q3 2025, worth a combined $56.9M — up 52% from $37.4M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new LABU positions and 7 closed out — a net gain of 6 holders — while 10 added to existing stakes and 10 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $6.49M. The largest seller was Tidal Investments, exiting entirely with an estimated $15.6M sold.
- 39 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q3 2025, up from 33 in Q2 2025.
- Funds reported $56.9M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q3 2025, up 52% quarter-over-quarter.
- 13 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q3 2025 and 7 closed out, a net change of +6 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q3 2025 was Citadel Advisors, an estimated $6.49M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q3 2025 was Tidal Investments, an estimated $15.6M sold.
Based on aggregated 13F filings for Q3 2025.